Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

Share Price is delayed by 15 minutes
Get Live Data
164.40    0.00 (0.00%)
Bid:
162.80
Ask:
166.00
Spread: 3.20 (1.966%)
Market Cap: -
SAN Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.10te% Share Chart

Board Changes at Santander UK plc

25 Sep 2013 08:28

RNS Number : 8455O
Santander UK Plc
25 September 2013
 



Santander UK plc

Board Change

 

Santander UK plc has today announced the appointments of Alain Dromer and Scott Wheway as Non-Executive Directors of the Board with effect from 1 October 2013.

 

These appointments have been approved by the PRA and the FCA.

 

- Ends -

 

For further details, please contact:

 

Anthony Frost

(Head of UK Communications)

020 7756 6284

James S. Johnson

(Head of Investor Relations)

020 7756 5014

For more information contact:

ir@santander.co.uk

 

 

 

Notes to Editors:

 

1. Alain Dromer is an experienced financial services executive director. He has 25 years experience in asset management and capital markets in the UK and Europe, together with nearly 10 years experience with the French Treasury.

2. Alain Dromer was previously CEO of Aviva Investors; Global Head of Group Investment Business of HSBC Investments; Head of Asset Management at CCF Credit Commercial de France and Head of Capital Markets of La Compagnie Financiere Edmond de Rothschild Banque. Prior to that he held various roles in the Government of France, French Treasury including Section Head, World Monetary Affairs & IMF, and Deputy Head/Office of Financial Markets. He is currently a director of certain Moody's subsidiaries in Europe, including Moody's Investors Service Limited; and a director of Majid Al Futtaim Trust LLC.

3. Scott Wheway is an experienced executive director from the retail sector. He has nearly 30 years of retail experience in the UK and internationally, together with over 5 years experience as a non-executive within Financial Services.

4. Scott Wheway was CEO of Best Buy Europe and MD of Boots the Chemist, prior to which he held various senior roles within Tesco plc, including Operations Director and CEO, Tesco Japan. He is currently a non-executive director of Aviva plc where he is chair of the Remuneration Committee and a Member of the CSR Committee.

5. Scott Wheway's full name is "Jonathan Scott Wheway", although he is known as "Scott".

 

 

 

Additional information about Santander UK and Banco Santander, S.A.

Banco Santander (SAN.MC, STD.N, BNC.LN) is a retail and commercial bank, based in Spain, with a presence in 10 main markets. Banco Santander is the largest bank in the euro zone by market capitalisation. Founded in 1857, Banco Santander had EUR 1,388 trillion in managed funds, 102 million customers, 14,392 branches - more than any other international bank - and 187,000 employees at the close of 2012. It is the largest financial group in Spain and Latin America. It also has significant positions in the United Kingdom, Portugal, Germany, Poland and the northeast United States. Santander had a pre-provision profit of EUR 23,559 billion in 2012, an increase of 2% from the previous year.

 

Santander UK is a leading financial services provider in the UK and offers a wide range of personal and commercial financial products and services. With 1,187 branches (including agencies), 36 regional Corporate Business Centres and c. 24,000 employees (on a group basis), Santander UK serves more than 15 million active customers as at 30 June 2013.

 

Banco Santander has a standard listing of its ordinary shares on the London Stock Exchange and Santander UK continues to have its preference shares listed on the London Stock Exchange. Nothing in this announcement constitutes or should be construed as constituting a profit forecast. Further information about Santander UK is available at the group's website: www.aboutsantander.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAXNSAAXDEEF
Date   Source Headline
17th Aug 20181:17 pmRNSForm 8.3 - Shire plc
17th Aug 20181:16 pmRNSForm 8.3 - Shire plc
17th Aug 20181:15 pmRNSForm 8.3 - Shire plc
14th Aug 20181:47 pmRNSPublication of Final Terms
10th Aug 20185:28 pmRNSPublication of Suppl.Prospcts
10th Aug 20187:15 amRNSHalf-year Report
10th Aug 20187:15 amRNSHalf-year Report
25th Jul 20182:24 pmRNSPublication of Suppl.Prospcts
25th Jul 20182:16 pmRNSPublication of Suppl.Prospcts
25th Jul 20187:15 amRNSQuarterly Management Statement - 30 June 2018
9th Jul 20184:24 pmRNSArticle 8
9th Jul 201812:02 pmRNSNotice of Delisting
25th Jun 201812:31 pmRNSPublication of Suppl.Prospcts
25th Jun 201812:26 pmRNSPublication of Suppl.Prospcts
13th Jun 201810:47 amRNSApproval of Ring-Fencing Transfer Scheme
31st May 201810:53 amRNSDirectorate Change
14th May 20182:24 pmRNSArticle 8
14th May 201811:29 amRNSNotice of Delisting - Series 1125
8th May 20184:21 pmRNSPublication of Final Terms
8th May 20183:26 pmRNSPublication of Final Terms
4th May 201812:41 pmRNSPublication of Final Terms
27th Apr 20184:47 pmRNSStatement re Change of Paying & Transfer Agent
27th Apr 201811:46 amRNSNotice Change of Agent
24th Apr 20186:15 pmRNSPublication of a Prospectus
24th Apr 20182:36 pmRNSPublication of Suppl.Prospcts
24th Apr 20187:15 amRNS1st Quarter Results
13th Apr 20182:16 pmRNSPublication of Final Terms
11th Apr 20184:49 pmRNSOffer period extension Series 1125-1126
29th Mar 201811:29 amRNSArticle 8
28th Mar 20185:11 pmRNSPublication of Final Terms
26th Mar 20184:27 pmRNSArticle 8
19th Mar 20182:29 pmRNSDelisting notice - Series 1121 - XS1710683985
19th Mar 201811:52 amRNSArticle 8
12th Mar 201810:40 amRNSCall notice XS0907246812. Series 790
9th Mar 20183:46 pmRNSPublication of Final Terms
2nd Mar 20184:31 pmRNSPre-Stab: Santander, GBP 50m Tap, due 27/02/2020
2nd Mar 20184:14 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:10 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:02 pmRNSPublication of Final Terms
2nd Mar 20183:58 pmRNSPublication of Final Terms
28th Feb 201812:45 pmRNSAnnual Financial Report
28th Feb 201812:40 pmRNSAnnual Financial Report
26th Feb 20185:20 pmRNSPublication of Final Terms
23rd Feb 20182:47 pmRNSArticle 8
22nd Feb 20185:34 pmRNSPre-Stab Notice - SANUK, GBP 250m, due 27/02/2020
12th Feb 201810:58 amRNSNotice of Early Redemption
7th Feb 20185:43 pmRNSPublication of Suppl.Prospcts
7th Feb 20185:39 pmRNSPublication of Suppl.Prospcts
6th Feb 201811:41 amRNSUpdate on Ring-fencing & Part VII Transfer Scheme
31st Jan 20187:15 amRNSQ4 17 - Quarterly Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.